Zhejiang Haixiang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
I. Introduction to Abnormal Stock Trading Fluctuations
The stock of Zhejiang Haixiang Pharmaceutical Co., Ltd. (stock abbreviation: Haixiang Pharmaceutical, stock code: 002099) experienced a cumulative price increase deviation of over 20% during three consecutive trading days on February 6, 2026, February 9, 2026, and February 10, 2026. This situation falls under the category of abnormal stock trading fluctuations according to the relevant regulations of the Shenzhen Stock Exchange (hereinafter referred to as "SZSE").